Riggs Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Riggs Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-38	Closed	-$1.76K	–	222
2025 Q2	$1.76K	Hold	38	–	–	﹤0.01%	678
2025 Q1	$2.32K	Sell	38 -10	-21%	-$583	﹤0.01%	390
2024 Q4	$2.69K	Buy	48 +30	+167%	+$1.68K	﹤0.01%	351
2024 Q3	$932	Buy	18 +11	+157%	+$516	﹤0.01%	450
2024 Q2	$291	Buy	+7	New	+$313	﹤0.01%	613
2023 Q4	–	Sell	-440	Closed	-$25.5K	–	429
2023 Q3	$25.5K	Hold	440	–	–	0.01%	175
2023 Q2	$28.1K	Hold	440	–	–	0.01%	169
2023 Q1	$30.5K	Sell	440 -811	-65%	-$57.2K	0.01%	158
2022 Q4	$90K	Hold	1,251	–	–	0.04%	111
2022 Q3	$89K	Hold	1,251	–	–	0.04%	111
2022 Q2	$96K	Buy	1,251 +51	+4%	+$3.88K	0.04%	107
2022 Q1	$88K	Sell	1,200 -42	-3%	-$2.82K	0.03%	126
2021 Q4	$77K	Sell	1,242 -1,471	-54%	-$86.3K	0.02%	141
2021 Q3	$161K	Sell	2,713 -80,439	-97%	-$5.3M	0.05%	100
2021 Q2	$5.56M	Buy	83,152 +7,885	+10%	+$514K	1.55%	25
2021 Q1	$4.75M	Sell	75,267 -25,716	-25%	-$1.6M	1.44%	29
2020 Q4	$6.26M	Sell	100,983 -3,739	-4%	-$230K	1.92%	24
2020 Q3	$6.3M	Sell	104,722 -992	-0.9%	-$59.7K	2.66%	16
2020 Q2	$6.21M	Buy	105,714 +1,680	+2%	+$100K	2.52%	17
2020 Q1	$5.8M	Sell	104,034 -2,298	-2%	-$140K	3.73%	7
2019 Q4	$6.83M	Buy	106,332 +102,932	+3,027%	+$5.89M	2.75%	11
2019 Q3	$172K	Hold	3,400	–	–	0.09%	63
2019 Q2	$154K	Buy	3,400 +200	+6%	+$9.32K	0.09%	66
2019 Q1	$152K	Sell	3,200 -745	-19%	-$37.1K	0.1%	62
2018 Q4	$205K	Hold	3,945	–	–	0.15%	48
2018 Q3	$244K	Hold	3,945	–	–	0.12%	45
2018 Q2	$218K	Hold	3,945	–	–	0.1%	51
2018 Q1	$250K	Buy	3,945 +3,000	+317%	+$193K	0.1%	56
2017 Q4	$58K	Hold	945	–	–	0.02%	112
2017 Q3	$60K	Sell	945 -200	-17%	-$11.7K	0.03%	113
2017 Q2	$64K	Hold	1,145	–	–	0.03%	112
2017 Q1	$62K	Hold	1,145	–	–	0.03%	105
2016 Q4	$67K	Hold	1,145	–	–	0.03%	102
2016 Q3	$62K	Hold	1,145	–	–	0.03%	105
2016 Q2	$84K	Sell	1,145 -591	-34%	-$41.8K	0.04%	96
2016 Q1	$111K	Hold	1,736	–	–	0.08%	68
2015 Q4	$119K	Hold	1,736	–	–	0.06%	71
2015 Q3	$103K	Buy	1,736 +1,186	+216%	+$75.2K	0.06%	66
2015 Q2	$37K	Buy	550 +150	+38%	+$9.88K	0.02%	129
2015 Q1	$26K	Hold	400	–	–	0.01%	146
2014 Q4	$24K	Hold	400	–	–	0.01%	155
2014 Q3	$20K	Buy	+400	New	+$20K	0.01%	158

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Riggs Asset Management's BMY Position: Q3 2025 in Review

Riggs Asset Management sold out of Bristol-Myers Squibb (BMY) in Q3 2025, closing a stake of 38 shares — an estimated $1.76K sold.

Riggs Asset Management first reported a position in BMY in Q3 2014 and held it in 42 quarters. The position peaked at $6.83M in Q4 2019. 2,267 funds tracked by Wall St. Rank hold BMY as of Q3 2025.

Riggs Asset Management reported no remaining Bristol-Myers Squibb position as of Q3 2025 after selling out during the quarter.
Riggs Asset Management sold 38 Bristol-Myers Squibb shares in Q3 2025, an estimated $1.76K.
Riggs Asset Management first reported a position in Bristol-Myers Squibb in Q3 2014 and held it in 42 quarters.
Riggs Asset Management's Bristol-Myers Squibb position peaked at $6.83M in Q4 2019.
2,267 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2025.

Based on Riggs Asset Management's 13F filing for Q3 2025, filed 13 Nov 2025.